Literature DB >> 18007203

Homocysteine induces tau hyperphosphorylation in rats.

Yougen Luo1, Xinwen Zhou, Xifei Yang, Jianzhi Wang.   

Abstract

Epidemiological and clinical data suggest that homocysteine (Hcy) may increase the risk of Alzheimer's disease, but the underlying mechanisms are elusive. To investigate the effect of Hcy on phosphorylation of tau, we injected Hcy into the lateral cerebral ventricle of rats. We found that level of the hyperphosphorylated tau at PHF-1 (Ser396/404) and tau-1 (Ser198/199/202) epitopes was elevated prominently at 6, 9, and 12 h after the injection, and it was recovered to normal at 24 h. Simultaneously, the level of protein phosphatase-2A catalytic subunit (PP-2Ac) was reduced markedly as compared with control. These results imply that Hcy may induce hyperphosphorylation of tau with PP-2Ac involved mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007203     DOI: 10.1097/WNR.0b013e3282f29100

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

3.  S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons.

Authors:  Weizhen Ye; Stacy W Blain
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

Review 4.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

5.  Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.

Authors:  Jean-Marie Sontag; Viyada Nunbhakdi-Craig; Lisa Montgomery; Erland Arning; Teodoro Bottiglieri; Estelle Sontag
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Genetic influence of plasma homocysteine on Alzheimer's disease.

Authors:  Tina Roostaei; Daniel Felsky; Arash Nazeri; Philip L De Jager; Julie A Schneider; David A Bennett; Aristotle N Voineskos
Journal:  Neurobiol Aging       Date:  2017-10-13       Impact factor: 4.673

8.  Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.

Authors:  I V Litvinenko; M M Odinak; V I Mogil'naya; S V Perstnev
Journal:  Neurosci Behav Physiol       Date:  2010-02

9.  Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults.

Authors:  Jeffery M Reddan; David J White; Helen Macpherson; Andrew Scholey; Andrew Pipingas
Journal:  Front Aging Neurosci       Date:  2018-03-07       Impact factor: 5.750

10.  Circumventing embryonic lethality with Lcmt1 deficiency: generation of hypomorphic Lcmt1 mice with reduced protein phosphatase 2A methyltransferase expression and defects in insulin signaling.

Authors:  Kennen B MacKay; Yiping Tu; Stephen G Young; Steven G Clarke
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.